Rapamycin augments human DC IL-12p70 and IL-27 secretion to promote allogeneic type1 polarization modulated by NK cells

American Journal of Transplantation

Volumn 13, Issue 9, 2013, Pages 2322-2333

  Macedo, C ^a   Turnquist, H R ^a,b   Castillo Rama, M ^a   Zahorchak, A F ^a   Shapiro, R ^a   Thomson, A W ^a,b   Metes, D ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Dendritic cells; human; NK cells; rapamycin

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 27; RAPAMYCIN;

ALLOIMMUNITY; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; GRAFT REJECTION; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

DENDRITIC CELLS; HUMAN; NK CELLS; RAPAMYCIN;

CELL DIFFERENTIATION; COCULTURE TECHNIQUES; DENDRITIC CELLS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-27; KILLER CELLS, NATURAL; LEUKOCYTES, MONONUCLEAR; SIROLIMUS; T-LYMPHOCYTES;

EID: 84883456574     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12351     Document Type: Article

References (52)

1. Banchereau J, Steinman RM., Dendritic cells and the control of immunity. Nature 1998; 392: 245-252.
2. Morelli AE, Thomson AW., Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol 2007; 7: 610-621.
3. Hackstein H, Thomson AW., Dendritic cells: Emerging pharmacological targets of immunosuppressive drugs. Nat Rev Immunol 2004; 4: 24-34.
4. Thomson AW, Turnquist HR, Raimondi G., Immunoregulatory functions of mTOR inhibition. Nat Rev Immunol 2009; 9: 324-337.
5. Taner T, Hackstein H, Wang Z, Morelli AE, Thomson AW., Rapamycin-treated, alloantigen-pulsed host dendritic cells induce ag-specific T cell regulation and prolong graft survival. Am J Transplant 2005; 5: 228-236.
6. Turnquist HR, Raimondi G, Zahorchak AF, Fischer RT, Wang Z, Thomson AW., Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance. J Immunol 2007; 178: 7018-7031.
7. Reichardt W, Durr C, von Elverfeldt D, et al. Impact of mammalian target of rapamycin inhibition on lymphoid homing and tolerogenic function of nanoparticle-labeled dendritic cells following allogeneic hematopoietic cell transplantation. J Immunol 2008; 181: 4770-4779.
8. Weichhart T, Saemann MD., The multiple facets of mTOR in immunity. Trends Immunol 2009; 30: 218-226.
9. Turnquist HR, Cardinal J, Macedo C, et al. mTOR and GSK-3 shape the CD4+ T-cell stimulatory and differentiation capacity of myeloid DCs after exposure to LPS. Blood 2010; 115: 4758-4769.
10. Chi H., Regulation and function of mTOR signalling in T cell fate decisions. Nat Rev Immunol 2012; 12: 325-338.
11. Delgoffe GM, Pollizzi KN, Waickman AT, et al. The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nat Immunol 2011; 12: 295-303.
12. Hackstein H, Taner T, Logar AJ, Thomson AW., Rapamycin inhibits macropinocytosis and mannose receptor-mediated endocytosis by bone marrow-derived dendritic cells. Blood 2002; 100: 1084-1087.
13. Ikeguchi R, Sacks JM, Unadkat JV, et al. Long-term survival of limb allografts induced by pharmacologically conditioned, donor alloantigen-pulsed dendritic cells without maintenance immunosuppression. Transplantation 2008; 85: 237-246.
14. Weichhart T, Costantino G, Poglitsch M, et al. The TSC-mTOR signaling pathway regulates the innate inflammatory response. Immunity 2008; 29: 565-577.
15. Haidinger M, Poglitsch M, Geyeregger R, et al. A versatile role of mammalian target of rapamycin in human dendritic cell function and differentiation. J Immunol 2010; 185: 3919-3931.
16. Naranjo-Gomez M, Raich-Regue D, Onate C, et al. Comparative study of clinical grade human tolerogenic dendritic cells. J Transl Med 2011; 9: 1-14.
17. Boks MA, Kager-Groenland JR, Haasjes MS, Zwaginga JJ, van Ham SM, ten Brinke A., IL-10-generated tolerogenic dendritic cells are optimal for functional regulatory T cell induction-A comparative study of human clinical-applicable DC. Clin Immunol 2012; 142: 332-342.
18. Saemann MD, Remuzzi G., Transplantation: Time to rethink immunosuppression by mTOR inhibitors ? Nat Rev Nephrol 2009; 5: 611-612.
19. Brouard S, Puig-Pey I, Lozano JJ, et al. Comparative transcriptional and phenotypic peripheral blood analysis of kidney recipients under cyclosporin A or sirolimus monotherapy. Am J Transplant 2010; 10: 2604-2614.
20. Ferrer IR, Wagener ME, Robertson JM, et al. Cutting edge: Rapamycin augments pathogen-specific but not graft-reactive CD8+ T cell responses. J Immunol 2010; 185: 2004-2008.
21. Snijders A, Kalinski P, Hilkens CM, Kapsenberg ML., High-level IL-12 production by human dendritic cells requires two signals. Int Immunol 1998; 10: 1593-1598.
22. Vivier E, Raulet DH, Moretta A, et al. Innate or adaptive immunity? The example of natural killer cells. Science 2011; 331: 44-49.
23. Smyth MJ, Hayakawa Y, Takeda K, Yagita H., New aspects of natural-killer-cell surveillance and therapy of cancer. Nat Rev Cancer 2002; 2: 850-861.
24. Vesely MD, Kershaw MH, Schreiber RD, Smyth MJ., Natural innate and adaptive immunity to cancer. Annu Rev Immunol 2011; 29: 235-271.
25. Caligiuri MA., Human natural killer cells. Blood 2008; 112: 461-469.
26. Cooper MA, Fehniger TA, Turner SC, et al. Human natural killer cells: A unique innate immunoregulatory role for the CD56(bright) subset. Blood 2001; 97: 3146-3151.
27. Andoniou CE, Coudert JD, Degli-Esposti MA., Killers and beyond: NK-cell-mediated control of immune responses. Eur J Immunol 2008; 38: 2938-2942.
28. Martin-Fontecha A, Thomsen LL, Brett S, et al. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol 2004; 5: 1260-1265.
29. Macedo C, Popescu I, Abu-Elmagd K, et al. Augmentation of type-1 polarizing ability of monocyte-derived dendritic cells from chronically immunosuppressed organ-transplant recipients. Transplantation 2005; 79: 451-459.
30. Kalinski P., Dendritic cells in immunotherapy of established cancer: Roles of signals 1, 2, 3 and 4. Curr Opin Investig Drugs 2009; 10: 526-535.
31. Morelli AE, Larregina AT, Ganster RW, et al. Recombinant adenovirus induces maturation of dendritic cells via an NF-kappaB-dependent pathway. J Virol 2000; 74: 9617-9628.
32. Macedo C, Orkis EA, Popescu I, et al. Contribution of naive and memory T-cell populations to the human alloimmune response. Am J Transplant 2009; 9: 2057-2066.
33. Schmitz F, Heit A, Dreher S, et al. Mammalian target of rapamycin (mTOR) orchestrates the defense program of innate immune cells. Eur J Immunol 2008; 38: 2981-2992.
34. Villarino AV, Huang E, Hunter CA., Understanding the pro- and anti-inflammatory properties of IL-27. J Immunol 2004; 173: 715-720.
35. Trinchieri G., Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 2003; 3: 133-146.
36. Matsui M, Kishida T, Nakano H, et al. Interleukin-27 activates natural killer cells and suppresses NK-resistant head and neck squamous cell carcinoma through inducing antibody-dependent cellular cytotoxicity. Cancer Res 2009; 69: 2523-2530.
37. Kalinski P, Nakamura Y, Watchmaker P, Giermasz A, Muthuswamy R, Mailliard RB., Helper roles of NK and CD8+ T cells in the induction of tumor immunity. Polarized dendritic cells as cancer vaccines. Immunol Res 2006; 36: 137-146.
38. Jonuleit H, Knop J, Enk AH., Cytokines and their effects on maturation, differentiation and migration of dendritic cells. Arch Dermatol Res 1996; 289: 1-8.
39. Vieira PL, de Jong EC, Wierenga EA, Kapsenberg ML, Kalinski P., Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction. J Immunol 2000; 164: 4507-4512.
40. Riella LV, Paterson AM, Sharpe AH, Chandraker A., Role of the PD-1 pathway in the immune response. Am J Transplant 2012; 12: 2575-2587.
41. Ohtani M, Nagai S, Kondo S, et al. Mammalian target of rapamycin and glycogen synthase kinase 3 differentially regulate lipopolysaccharide-induced interleukin-12 production in dendritic cells. Blood 2008; 112: 635-643.
42. de Groot R, van Beelen AJ, Bakdash G, Taanman-Kueter EW, de Jong EC, Kapsenberg ML., Viral dsRNA-activated human dendritic cells produce IL-27, which selectively promotes cytotoxicity in naive CD8+ T cells. J Leukoc Biol 2012; 92: 605-610.
43. Awasthi A, Carrier Y, Peron JP, et al. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat Immunol 2007; 8: 1380-1389.
44. Stumhofer JS, Hunter CA., Advances in understanding the anti-inflammatory properties of IL-27. Immunol Lett 2008; 117: 123-130.
45. Saraiva M, O'Garra A., The regulation of IL-10 production by immune cells. Nat Rev Immunol 2010; 10: 170-181.
46. Borg C, Jalil A, Laderach D, et al. NK cell activation by dendritic cells (DCs) requires the formation of a synapse leading to IL-12 polarization in DCs. Blood 2004; 104: 3267-3275.
47. Ferrer IR, Araki K, Ford ML., Paradoxical aspects of rapamycin immunobiology in transplantation. Am J Transplant 2011; 11: 654-659.
48. Burrows SR, Khanna R, Burrows JM, Moss DJ., An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: Implications for graft-versus-host disease. J Exp Med 1994; 179: 1155-1161.
49. van der Touw W, Bromberg JS., Natural killer cells and the immune response in solid organ transplantation. Am J Transplant 2010; 10: 1354-1358.
50. Beilke JN, Gill RG., Frontiers in nephrology: The varied faces of natural killer cells in transplantation-Contributions to both allograft immunity and tolerance. J Am Soc Nephrol 2007; 18: 2262-2267.
51. Yu G, Xu X, Vu MD, Kilpatrick ED, Li XC., NK cells promote transplant tolerance by killing donor antigen-presenting cells. J Exp Med 2006; 203: 1851-1858.
52. Laroni A, Gandhi R, Beynon V, Weiner HL., IL-27 imparts immunoregulatory function to human NK cell subsets. PLoS ONE 2011; 6: 1-6.